Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Recursion Pharmaceuticals Stock Price, Quotes and Forecasts
RXRXNASDAQ
Recursion Pharmaceuticals (RXRX) Forecast
NewsEarningsRecursion Pharmaceuticals (RXRX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Recursion Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:RXRX | Benzinga
Explore Recursion Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RXRX.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Recursion Pharmaceuticals (RXRX) stock?
You can purchase shares of Recursion Pharmaceuticals (NASDAQ:RXRX) through any online brokerage.
Who are Recursion Pharmaceuticals (RXRX) competitors?
Other companies in Recursion Pharmaceuticals’s space includes: Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX), Centessa Pharmaceuticals (NASDAQ:CNTA), Ascentage Pharma Group (NASDAQ:AAPG) and Arcutis Biotherapeutics (NASDAQ:ARQT).
What is the forecast, or price target, for Recursion Pharmaceuticals (RXRX) stock?
Recursion Pharmaceuticals has a consensus price target of $11.56.
What is the current price for Recursion Pharmaceuticals (RXRX)?
The stock price for Recursion Pharmaceuticals (NASDAQ: RXRX) is $5.285 last updated March 31, 2025 at 12:06 PM EDT.
Does Recursion Pharmaceuticals (RXRX) pay a dividend?
There are no upcoming dividends for Recursion Pharmaceuticals.
When is Recursion Pharmaceuticals (NASDAQ:RXRX) reporting earnings?
Recursion Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is Recursion Pharmaceuticals (RXRX) going to split?
There is no upcoming split for Recursion Pharmaceuticals.
What sector and industry does Recursion Pharmaceuticals (RXRX) operate in?
Recursion Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.